Functional improvement of focal cerebral ischemia injury by subdural transplantation of induced pluripotent stem cells with fibrin glue

Stem Cells and Development

Volumn 19, Issue 11, 2010, Pages 1757-1767

  Chen, Shih Jen ^a,b   Chang, Chia Ming ^a,b   Tsai, Shen Kou ^b,c   Chang, Yuh Lih ^d,e   Chou, Shih Jie ^d   Huang, Shiang Suo ^f   Tai, Lung Kuo ^d   Chen, Yu Chih ^b,d   Ku, Hung Hai ^g   Li, Hsin Yang ^a,g   Chiou, Shih Hwa ^a,b,d,e  

^a Department of Ophthalmology ^*  (Taiwan)

^b Institute of Clinical Medicine   (Taiwan)

^c CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^d TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^g Institute of Anatomy and Cell Biology   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN GLUE; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN ELECTROPHYSIOLOGY; BRAIN FUNCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; FIBROBLAST; GRIP STRENGTH; IATROGENIC DISEASE; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR PERFORMANCE; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ROTAROD TEST; TREATMENT OUTCOME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; FIBRIN TISSUE ADHESIVE; FIBROBLASTS; INDUCED PLURIPOTENT STEM CELLS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; NEUROPSYCHOLOGICAL TESTS; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, LONG-EVANS; STEM CELL TRANSPLANTATION; SUBDURAL SPACE;

IPS; RATTUS;

EID: 77952884942     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0452     Document Type: Article

References (38)

1. Hossmann KA. (2006). Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 26: 1057-1083.
2. Minger SL, A Ekonomou, EM Carta, A Chinoy, RH Perry and CG Ballard. (2007). Endogenous neurogenesis in the human brain following cerebral infarction. Regen Med 2: 69-74.
3. Li HL, N Kostulas, YM Huang, BG Xiao, P van der Meide, V Kostulas, V Giedraitas and H Link. (2001). IL-17 and IFN-gamma mRNA expression is increased in the brain and systemically after permanent middle cerebral artery occlusion in the rat. J Neuroimmunol 116: 5-14.
4. Miszta-Lane H, M Mirbolooki, AM James Shapiro and JR Lakey. (2006). Stem cell sources for clinical islet transplantation in type 1 diabetes: embryonic and adult stem cells. Med Hypotheses 67: 909-913.
5. Takahashi K, T Yasuhara, T Shingo, K Muraoka, M Kameda, A Takeuchi, A Yano, K Kurozumi, T Agari, Y Miyoshi, K Kinugasa and I Date. (2008). Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Res 1234: 172-182.
6. Yanagisawa D, M Qi, DH Kim, Y Kitamura, M Inden, D Tsuchiya, K Takata, T Taniguchi, K Yoshimoto, S Shimohama, A Akaike, S Sumi and K Inoue. (2006). Improvement of focal ischemia-induced rat dopaminergic dysfunction by striatal transplantation of mouse embryonic stem cells. Neurosci Lett 407: 74-79.
7. Park IH, R Zhao, JA West, A Yabuuchi, H Huo, TA Ince, PH Lerou, MW Lensch and GQ Daley. (2008). Reprogramming of human somatic cells to pluripotency with defi ned factors. Nature 451: 141-146.
8. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
9. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fi broblasts by defi ned factors. Cell 131: 861-872.
10. Yu J, MA Vodyanik, K Smuga-Otto, J Antosiewicz-Bourget, JL Frane, S Tian, J Nie, GA Jonsdottir, V Ruotti, R Stewart, II Slukvin and JA Thomson. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
11. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fi broblast cultures by defi ned factors. Cell 126: 663-676.
12. Cheng H, S Almstrom and L Olson. (1995). Fibrin glue used as an adhesive agent in CNS tissues. J Neural Transplant Plast 5: 233-243.
13. Cheng H, B Hoffer, I Strömberg, D Russell and L Olson. (1995). The effect of glial cell line-derived neurotrophic factor in fi brin glue on developing dopamine neurons. Exp Brain Res 104: 199-206.
14. Cheng H, M Fraidakis, B Blomback, P Lapchak, B Hoffer and L Olson. (1998). Characterization of a fi brin glue-GDNF slowrelease preparation. Cell Transplant 7: 53-61.
15. Kao CL, LK Tai, SH Chiou, YJ Chen, KS Lee, SJ Chou, YL Chang, CM Chang, SJ Chen, HH Ku and HY Li. (2009). Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev.[Epub ahead of print]
16. Vendrame M, J Cassady, J Newcomb, T Butler, KR Pennypacker, T Zigova, CD Sanberg, PR Sanberg and AE Willing. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral defi cits and reduces infarct volume. Stroke 35: 2390-2395.
17. Bertelli JA and JC Mira. (1995). The grasping test: a simple behavioral method for objective quantitative assessment of peripheral nerve regeneration in the rat. J Neurosci Methods 58: 151-155.
18. Cheng H, SS Huang, SM Lin, MJ Lin, YC Chu, CL Chih, MJ Tsai, HC Lin, WC Huang and SK Tsai. (2005). The neuroprotective effect of glial cell line-derived neurotrophic factor in fi brin glue against chronic focal cerebral ischemia in conscious rats. Brain Res 1033: 28-33.
19. Chiou SH, CL Kao, CH Peng, SJ Chen, YW Tarng, HH Ku, YC Chen, YM Shyr, RS Liu, CJ Hsu, DM Yang, WM Hsu, CD Kuo and CH Lee. (2005). A novel in vitro retinal differentiation model by co-culturing adult human bone marrow stem cells with retinal pigmented epithelium cells. Biochem Biophys Res Commun 326: 578-585.
20. Chen YC, HS Hsu, YW Chen, TH Tsai, CK How, CY Wang, SC Hung, YL Chang, ML Tsai, YY Lee, HH Ku and SH Chiou. (2008). Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells. PLoS ONE 3: e2637.
21. Seminatore C, J Polentes, D Ellman, N Kozubenko, V Itier, S Tine, L Tritschler, M Brenot, E Guidou, J Blondeau, M Lhuillier, A Bugi, L Aubry, P Jendelova, E Sykova, AL Perrier, B Finsen and B Onteniente. (2010). The postischemic environment differentially impacts teratoma or tumor formation after transplantation of human embryonic stem cell-derived neural progenitors. Stroke 41: 153-159.
22. Schwarting S, S Litwak, W Hao, M Bähr, J Weise and H Neumann. (2008). Hematopoietic stem cells reduce postischemic infl ammation and ameliorate ischemic brain injury. Stroke 39: 2867-2875.
23. Bacigaluppi M, S Pluchino, L Peruzzotti Jametti, E Kilic, U Kilic, G Salani, E Brambilla, MJ West, G Comi, G Martino and DM Hermann. (2009). Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132 (Pt 8): 2239-2251.
24. Björklund A, SB Dunnett, P Brundin, AJ Stoessl, CR Freed, RE Breeze, M Levivier, M Peschanski, L Studer and R Barker. (2003). Neural transplantation for the treatment of Parkinson's disease. Lancet Neurol 2: 437-445.
25. Zhang D, W Jiang, M Liu, X Sui, X Yin, S Chen, Y Shi and H Deng. (2009). Highly effi cient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 19: 429-438.
26. Kamp TJ and GE Lyons. (2009). On the road to iPS cell cardiovascular applications. Circ Res 105: 617-619.
27. Wernig M, JP Zhao, J Pruszak, E Hedlund, D Fu, F Soldner, V Broccoli, M Constantine-Paton, O Isacson and R Jaenisch. (2008). Neurons derived from reprogrammed fi broblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc Natl Acad Sci USA 105: 5856-5861.
28. Cai J, M Yang, E Poremsky, S Kidd, JS Schneider and L Iacovitti. (2009). Dopaminergic neurons derived from human induced pluripotent stem cells survive and integrate into 6-OHDA lesioned rats. Stem Cells Dev.[Epub ahead of print]
29. Knoepfler PS. (2009). Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 27: 1050-1056.
30. Sugg RM, JK Pary, K Uchino, S Baraniuk, HM Shaltoni, NR Gonzales, R Mikulik, Z Garami, SG Shaw, DE Matherne, LA Moyé, AV Alexandrov and JC Grotta. (2006). Argatroban tPA stroke study: study design and results in the fi rst treated cohort. Arch Neurol 63: 1057-1062.
31. Weiner HL and DJ Selkoe. (2002). Infl ammation and therapeutic vaccination in CNS diseases. Nature 420: 879-884.
32. Stoll G, S Jander and M Schroeter. (1998). Infl ammation and glial responses in ischemic brain lesions. Prog Neurobiol 56: 149-171.
33. Vendrame M, C Gemma, D de Mesquita, L Collier, PC Bickford, CD Sanberg, PR Sanberg, KR Pennypacker and AE Willing. (2005). Anti-infl ammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev 14: 595-604.
34. Dirnagl U, C Iadecola and MA Moskowitz. (1999). Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22: 391-397.
35. Schroeter M and S Jander. (2005). T-cell cytokines in injury-induced neural damage and repair. Neuromolecular Med 7: 183-195.
36. Chen B, WQ Liao, N Xu, H Xu, JY Wen, CA Yu, XY Liu, CL Li, SM Zhao and W Campbell. (2009). Adiponectin protects against cerebral ischemia-reperfusion injury through anti-infl ammatory action. Brain Res 1273: 129-137.
37. Hirko AC, R Dallasen, S Jomura and Y Xu. (2008). Modulation of infl ammatory responses after global ischemia by transplanted umbilical cord matrix stem cells. Stem Cells 26: 2893-2901.
38. Vila N, J Castillo, A Dávalos, A Esteve, AM Planas and A Chamorro. (2003). Levels of anti-infl ammatory cytokines and neurological worsening in acute ischemic stroke. Stroke 34: 671-675.